BOSTON SCIENTIFIC CORP is 48.7x more valuable than AtriCure, Inc. by market capitalization ($70.11 B vs $1.44 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATRC | BSX |
|---|---|---|
| Market cap | $1.44 B | $70.11 B |
| US-listed rank | #2374 | #240 |
| Revenue (latest FY) | $534.53M | $20.07B |
| Net income (latest FY) | -$11.45M | - |
| Net margin | -2.1% | - |
| SEC filings | 1,531 | 1,009 |
BOSTON SCIENTIFIC CORP is 48.7x more valuable than AtriCure, Inc. by market capitalization ($70.11 B vs $1.44 B).
In their latest fiscal years, AtriCure, Inc. reported $534.53M in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: AtriCure, Inc. and BOSTON SCIENTIFIC CORP, or browse the full rankings.